MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Levodopa and DBS Produce Discordant Effects on Parkinsonian Features

    T. Lee, D. Ramesh, J. Perlmutter, J. Younce (Chapel Hill, USA)

    Objective: To compare the effect of levodopa vs deep brain stimulation on specific motor features of advanced Parkinson disease. Background: Levodopa (LD) is the gold…
  • 2025 International Congress

    A Data Visualization Tool to Improve Interpretation of MDS-UPDRS Results Post-DBS

    C. van Horne, G. Quintero, J. Hixson (Lexington, USA)

    Objective: To evaluate the potential of our previously developed data visualization platform for the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as a…
  • 2025 International Congress

    Full-year Open-label Tracking of Adaptive Deep Brain Stimulation in Parkinson’s Disease in Two Patients: Considerations for Long-term Algorithm Maintenance

    J. Yao, M. Shcherbakova, A. Hahn, L. Hammer, S. Cernera, C. Oehrn, S. Little, P. Starr (San Francisco, USA)

    Objective: To assess the effects of chronic adaptive deep brain stimulation (aDBS) on motor symptoms and quality of life (QoL) and algorithm stability in two…
  • 2025 International Congress

    Analgesic Effect of Cannabidiol and Tetrahydrocannabinol(THC) on Pain Sensitivity in Reserpine Model of Parkinson’s Disease

    T. Muhammad, A. Isa, H. Tanko (Kaduna, Nigeria)

    Objective: The objectives of the study were to determine the effect of THC and CBD on:1. Thermal nociceptive threshold in reserpine induced Parkinson’s disease2. Mechanical…
  • 2025 International Congress

    Qigong Exercise on Nonmotor Symptoms in Parkinson’s Disease

    W. Liu, I. Smirnova, Z. Liu, K. Lyons, R. Pahwa (Kansas City, USA)

    Objective: This randomized controlled clinical trial examined the efficacy of a Qigong exercise on non-motor symptoms in people with Parkinson’s disease (PD). Background: Non-motor symptoms…
  • 2025 International Congress

    Application of Respiratory-Controlled Cardiopulmonary Coupling in Early Diagnosis of Parkinson’s Disease

    HF. Zheng, PH. Zhu, J. Wang (najing, China)

    Objective: Studies have shown that autonomic nervous  symptoms precede motor symptoms in  PD, making autonomic function assessment a potential tool for early PD diagnosis. This…
  • 2025 International Congress

    Prevalence of urinary problems in men and women with Parkinson’s disease. A study from the Mexican Parkinson’s Research Network.

    A. Garcia, A. Fierro, A. Solari, P. Reyes, A. Lazaro, E. Morelos, C. Guerra, I. Estrada, K. Salinas, Y. Matuk, N. Gandarilla, U. Caballero, P. Montés, V. Flores, I. Espinosa, A. Hayas, E. Gaspar, D. Vazquez, M. Rodriguez, E. Waldo, T. Leal, M. Inca, I. Mata, S. Alcauter, M. Renteria, A. Medina, A. Ruiz (CDMX, Mexico)

    Objective: To analyze whether there is a relationship between sex and the presence of genitourinary symptoms in patients with Parkinson’s disease and its impact on…
  • 2025 International Congress

    Distribution of Chronotypes in Parkinson’s Disease and its association with Pathological Sleepiness

    A. Sarwar (Houston, USA)

    Objective: To study the distribution of chronotypes in Veterans with Parkinson's disease (PD); and its association with pathological sleepiness. Background: Excessive daytime sleepiness is a…
  • 2025 International Congress

    Genotype and age at onset drive vermis atrophy in CACNA1A and GAA-FGF14 related ataxias

    E. Indelicato, W. Nachbauer, M. Amprosi, E. Gizewski, S. Boesch, F. Krismer (Innsbruck, Austria)

    Objective: To assess cerebellar volumetry using a deep learning method in patients with non-polyglutamine CACNA1A- or GAA-FGF14-related disease. Background: Ion channel dysfunction is a recurring…
  • 2025 International Congress

    Multiplex Proteomic Analysis of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathophysiology and Progression

    L. Higginbotham, A. Shantaraman, Q. Guo, E. Fox, P. Bagchi, F. Wu, J. Lah, A. Levey, N. Seyfried (Altanta, USA)

    Objective: To evaluate the performance of a multiplexed proteomic assay in a large multi-center Lewy Body dementia (LBD) cohort. Background: LBD, which comprises Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley